CRISPR Therapeutics AG - CRSP - stock price prediction, stock price target, analyst ratings from 28 analysts

CRISPR Therapeutics AG has a share price target of US$ 82, revenue growth forecast of 27.7%, and profit growth estimate of -28.2% for FY25, based on top 28 analyst calls.